Mr Ramaswamy, the 39-year-old biotech investor and "anti-woke" advocate, has built a billion-dollar fortune through his drug-development company, Roivant Sciences, which went public in 2021.
Rivian isn't prioritizing autonomous driving, the company's chief software officer said in an interview with Business Insider. As Waymo and Tesla race to scale autonomous driving and usher in an ...